We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Sentinel Diagnostics

Sentinel Diagnostics develops and manufactures in-vitro diagnostic medical devices for routine analysis and specific ... read more Featured Products: More products

Download Mobile App





Sentinel Diagnostics Presents Latest Breakthroughs in Diagnostics

By LabMedica International staff writers
Posted on 12 Nov 2024

Sentinel Diagnostics (Milano, Italy) is sharing its latest breakthroughs in medical diagnostics at MEDICA 2024. More...

The company is also hosting exciting presentations on molecular diagnostics, fecal immunochemical testing (FIT), chromatography, and lateral flow tests.

At this year’s MEDICA, Sentinel is showcasing is wide portfolio of compatible freeze-dried kits based on its proprietary STAT-NAT (Stabilized Amplification Technology) technology that has been developed with a new protective compound able to stabilize the activity of enzymes for a very long time with no temperature-controlled storage requirements. STAT-NAT technology yields very good performances in all the most diffused molecular biology techniques. It can improve test sensitivity even with low-concentrated DNA samples and contains all the reaction components. Sentinel is also highlighting its lyophilized STAT-NAT kits for various application areas such as virology, healthcare-associated infections, parasitology, and respiratory infections.

Designed to work with the lyophilized kits is Sentinel’s SENTiNAT 200 molecular diagnostics system that contains everything needed to perform a complete PCR analysis- rom sample extraction to Real-Time PCR results interpretation. The fully automated multiparametric system for pathogens detection can perform a multiparametric analysis on different matrices from one or more patients, using the same extraction and amplification protocol. Smart software takes care of every step of the process from sample loading to the result analysis with visual and simple terms to avoid any human errors.

At MEDICA 2024, Sentinel is also highlighting FOBGold line, its complete line for fecal occult blood testing (FIT). This includes the SENTiFIT 270 high-speed FIT system with a throughput of up to 270 tests per hour and featuring a patented pierceable tube for high-volume CRC screening. Also being showcased is the SENTiFOB automated FIT system with a throughput of up to tests per and compatible with pierceable tubes. In addition, Sentinel is highlighting the CALiaGold quantitative latex immunoassay for fecal calprotectin measurement as a marker of intestinal inflammation. The CALiaGold solution, together with the SENTiFIT 270 and SENTiFOB automated analyzers, offers a specific diagnostic system to differentiate IBD (Inflammatory Bowel Disease) from IBS (Irritable Bowel Syndrome). Visitors to the Sentinel booth can also learn more about the FOB Gold system which comprises a unique “2 in 1” tube for sample collection and a new generation immunological latex reagent for the determination of FOB.

Related Links:
Sentinel Diagnostics 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Luteinizing Hormone Test
Luteinizing Hormone (LH) Rapid Test
New
HAV Rapid Test
OnSite HAV IgG/IgM Rapid Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.